Derenne, Aline
Tassin, Alexandra
Nguyen, Thuy Hang
De Roeck, Estelle
Jenart, Vincianne
Ansseau, Eugénie
Belayew, Alexandra
Coppée, Frédérique
Declèves, Anne-Emilie
Legrand, Alexandre
Funding for this research was provided by:
French Muscular Dystrophy Association (18916)
Ph.D. fellowships from the Belgian F.R.S-FNRS
Article History
Received: 1 February 2020
Accepted: 9 June 2020
First Online: 9 July 2020
Competing interests
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. However, regarding the experiment involving an antisense oligonucleotide (vPMO pLAM3A −12 + 13), we have to mention that FC, EA and AB are co-inventors on patent US2012225034A1.